DK170061B1 - Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus - Google Patents

Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus Download PDF

Info

Publication number
DK170061B1
DK170061B1 DK472083A DK472083A DK170061B1 DK 170061 B1 DK170061 B1 DK 170061B1 DK 472083 A DK472083 A DK 472083A DK 472083 A DK472083 A DK 472083A DK 170061 B1 DK170061 B1 DK 170061B1
Authority
DK
Denmark
Prior art keywords
virus
strain
vaccine
bvd
viral
Prior art date
Application number
DK472083A
Other languages
Danish (da)
English (en)
Other versions
DK472083A (da
DK472083D0 (da
Inventor
Jean-Claude Delgoffe
Michele Lobmann
Nathan Zygraich
Original Assignee
Smithkline Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Biolog filed Critical Smithkline Biolog
Publication of DK472083D0 publication Critical patent/DK472083D0/da
Publication of DK472083A publication Critical patent/DK472083A/da
Application granted granted Critical
Publication of DK170061B1 publication Critical patent/DK170061B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24363—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/813—Viral vaccine for bovine species, e.g. cattle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK472083A 1982-10-13 1983-10-13 Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus DK170061B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/434,155 US4618493A (en) 1982-10-13 1982-10-13 Temperature sensitive strains of bovine viral diarrhoea virus, preparation thereof and vaccines containing them
US43415582 1982-10-13

Publications (3)

Publication Number Publication Date
DK472083D0 DK472083D0 (da) 1983-10-13
DK472083A DK472083A (da) 1984-04-14
DK170061B1 true DK170061B1 (da) 1995-05-15

Family

ID=23723042

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472083A DK170061B1 (da) 1982-10-13 1983-10-13 Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus

Country Status (16)

Country Link
US (1) US4618493A (de)
EP (1) EP0106831B1 (de)
JP (3) JPS5989631A (de)
AT (1) ATE48948T1 (de)
AU (1) AU572050B2 (de)
CA (1) CA1216234A (de)
DE (1) DE3381005D1 (de)
DK (1) DK170061B1 (de)
ES (2) ES8600058A1 (de)
FI (1) FI82264C (de)
GR (1) GR78966B (de)
IE (1) IE56438B1 (de)
NO (1) NO166953C (de)
NZ (1) NZ205491A (de)
PT (1) PT77454B (de)
ZA (1) ZA837573B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052606A (en) * 1958-08-30 1962-09-04 Behringwerke Ag Viral mutation with nitrites
US3293129A (en) * 1962-02-01 1966-12-20 Cornell Res Foundation Inc Immunization of cattle against virus diarrhea virus
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
GB1390467A (en) * 1973-03-30 1975-04-16 Rit Rech Ind Therapeut Vaccination method using temperature sensitive virus mutants
US3927208A (en) * 1973-05-14 1975-12-16 Rit Rech Ind Therapeut Live bovine adenovirus vaccines, preparation thereof and method of vaccination using them
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
JPS5817084B2 (ja) * 1978-08-25 1983-04-05 新明和工業株式会社 塵芥押込処理装置の操作装置

Also Published As

Publication number Publication date
NO166953B (no) 1991-06-10
ATE48948T1 (de) 1990-01-15
NO833717L (no) 1984-04-16
ES526380A0 (es) 1985-04-16
AU1852983A (en) 1984-04-19
IE832400L (en) 1984-04-13
DK472083A (da) 1984-04-14
EP0106831A3 (en) 1986-01-22
FI833717A0 (fi) 1983-10-12
PT77454A (en) 1983-11-01
JPH0773494B2 (ja) 1995-08-09
GR78966B (de) 1984-10-02
JPH0773493B2 (ja) 1995-08-09
DK472083D0 (da) 1983-10-13
ES8504929A1 (es) 1985-04-16
JPS5989631A (ja) 1984-05-23
IE56438B1 (en) 1991-07-31
JPH0463862B2 (de) 1992-10-13
ES526382A0 (es) 1985-10-01
NZ205491A (en) 1989-07-27
JPH05176764A (ja) 1993-07-20
CA1216234A (en) 1987-01-06
DE3381005D1 (de) 1990-02-01
EP0106831B1 (de) 1989-12-27
EP0106831A2 (de) 1984-04-25
ES8600058A1 (es) 1985-10-01
NO166953C (no) 1991-09-18
PT77454B (en) 1986-02-26
FI82264B (fi) 1990-10-31
JPH05192139A (ja) 1993-08-03
US4618493A (en) 1986-10-21
ZA837573B (en) 1984-08-29
AU572050B2 (en) 1988-04-28
FI82264C (fi) 1991-02-11
FI833717A (fi) 1984-04-14

Similar Documents

Publication Publication Date Title
CA2225388C (en) Low pathogenicity prrs live virus vaccines and methods of preparation thereof
JP3068204B2 (ja) ブタの生殖・呼吸症候群（ｐｒｒｓ）を惹起するウイルスの新規弱毒化株、それに由来するワクチンおよび診断キットならびにそれらの取得方法。
Villegas Viral diseases of the respiratory system
DK163133B (da) Biologisk ren praeparation af en smitsom bronchitis-virusstamme
CN111135295A (zh) 一种大口黑鲈虹彩病毒病灭活疫苗及其制备方法
JP2018537996A (ja) ネコカリシウイルスワクチン
EP2658570A1 (de) Impfstoffzusammensetzungen für bovinen viralen diarrhöe-virustyp 1b und verfahren
Cubillos et al. Characterisation of strains of infectious bronchitis virus isolated in Chile
DK141339B (da) Fremgangsmåde til fremstilling af felin-calicivirus vaccine.
DK163067B (da) Biologisk ren praeparation af en smitsom bronkitis-virusstamme
RU2126268C1 (ru) Вакцина для профилактики инфекционного заболевания сумки у цыплят, лиофилизированная вирусная композиция, способ защиты цыплят от этого заболевания и способ получения живой вакцины
DK170061B1 (da) Fremgangsmåde til fremstilling af modificerede stammer af viral kvægdiarrevirus samt fremgangsmåde til fremstilling af en vaccine mod infektion med viral kvægdiarrevirus
Reed Persistent respiratory virus infection in tracheal organ cultures
KR20000075775A (ko) 백신으로서 소 호흡 코로나바이러스
US4714678A (en) Temperature sensitive strain of bovine viral diarrhoea virus
JP4664901B2 (ja) 不活性化ノダウイルスワクチン
IE44691B1 (en) Feline distempr vaccine
McFerran et al. Recent advances in enterovirus infections of birds
EP0427767B1 (de) Impfstoff
US6416764B1 (en) Vaccine
El‐Zein et al. Preparation and testing of a goat pox vaccine from a pathogenic field isolate attenuated in cell culture
Losio et al. A study on the characteristics of La Sota strain of Newcastle disease virus adapted to grow in a cell line from bovine embryo kidney (BS/BEK)
MXPA02002566A (es) Mutante del virus de herpes equino sensible a la temperatura y vacuna viva del mismo.
MXPA97010149A (en) Live pathogenicity live virus vaccines and methods of preparation of mis
MXPA97007302A (en) New attenuated cepa of the virus causing the respiratory and reproductive swine syndrome (prrs), vaccines and diagnostic media obtained with the same and the procedures for your obtenc

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK